Monarch Energy Changes Its Name to ChroMedX Corp.

Toronto, Ontario
September 17, 2014

Monarch Energy Limited (CSE: CHX) (the "Company") is pleased to announce that pursuant to articles of continuance dated September 8, 2014, Monarch Energy Limited has continued from the province of British Columbia to the Province of Ontario and has changed its name to "ChroMedX Corp."

The common shares of the Company will begin trading under its new name on September 18, 2014 under the current trading symbol "CHX".

About ChroMedX

ChroMedX is an early stage company focused on the development of novel medical devices for in vitro diagnostics and point-of-care testing. The devices are protected by the Company's issued US and pending international patents, dealing with blood collection, analysis and plasma/serum processing. Application of the devices is extended to address special requirements for neonatal care.

For further information, please contact Wayne Maddever, CEO at 647-872-9982 or Clark Kent, Corporate Development, 647-519-2646, ckent@chromedx.com Website: www.chromedx.com

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Forward-looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which filings are available atwww.sedar.com.